When left untreated, fatty liver disease can lead to inflammation, scarring, and even cirrhosis
Even in patients with a prior history of pancreatitis, newer data suggest that GLP-1 RAs are not automatically contraindicated, with recurrence rates comparable to or lower than those seen with other treatments
Future Research Goals So far, most evidence comes from retrospective studies or case reports, not from large randomized clinical trials, says Tariq, who says that experts are still looking to understand: Whether GLP-1s directly reduce intestinal inflammation How GLP-1s interact with the immune system and the gut microbiome Whether they are as effective in people with active Crohns disease as with those in remission Current research findings show promise, but Tariq encourages her patients to view them as early signals instead of established treatments
For female athletes, already disproportionately vulnerable to these conditions, the risks are particularly acute
Reducing Postpartum Weight Retention: A Review of the Implementation Challenges of Postpartum Lifestyle Interventions
Always consult with a healthcare professional to optimize your results and avoid unnecessary risks